366 related articles for article (PubMed ID: 15235527)
1. [Ten years of clinical experience with clozapine about 170 patients].
Levoyer D; Martinet JP; Badiche A; Millet B
Encephale; 2004; 30(3):285-95. PubMed ID: 15235527
[TBL] [Abstract][Full Text] [Related]
2. [Retrospective study of clozapine use in Ile-de-France].
Hiltgen S; Mantelet S; Pinabel F; Enjaume F
Encephale; 2006 Oct; 32(5 Pt 1):688-96. PubMed ID: 17099592
[TBL] [Abstract][Full Text] [Related]
3. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
4. Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.
Lau KL; Yim PH
East Asian Arch Psychiatry; 2015 Dec; 25(4):164-7. PubMed ID: 26764291
[TBL] [Abstract][Full Text] [Related]
5. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
BMC Psychiatry; 2016 Dec; 16(1):441. PubMed ID: 27955666
[TBL] [Abstract][Full Text] [Related]
6. A follow-up study of a population of schizophrenic patients treated with clozapine.
Bourin M; Guitton B; Dailly E; Hery P; Jolliet P
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Nov; 25(8):1481-95. PubMed ID: 11642649
[TBL] [Abstract][Full Text] [Related]
7. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
8. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
Mercier C; Bret P; Bret MC; Queuille E
Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
[TBL] [Abstract][Full Text] [Related]
9. Clozapine dose for schizophrenia.
Subramanian S; Völlm BA; Huband N
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009555. PubMed ID: 28613395
[TBL] [Abstract][Full Text] [Related]
10. [Long-term clinical experience with clozapine].
Gelly F; Chambon O; Marie-Cardine M
Encephale; 1997; 23(5):385-96. PubMed ID: 9453932
[TBL] [Abstract][Full Text] [Related]
11. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
12. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
Simon L; Cazard F
Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
[TBL] [Abstract][Full Text] [Related]
13. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.
Atkin K; Kendall F; Gould D; Freeman H; Liberman J; O'Sullivan D
Br J Psychiatry; 1996 Oct; 169(4):483-8. PubMed ID: 8894200
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study on the long-term efficacy of clozapine in 96 schizophrenic and schizoaffective patients during a 13-year period.
Lindström LH
Psychopharmacology (Berl); 1989; 99 Suppl():S84-6. PubMed ID: 2813670
[TBL] [Abstract][Full Text] [Related]
15. [Granulocytopenia while using clozapine: continuing or stopping treatment].
Bogers JP
Tijdschr Psychiatr; 2007; 49(8):575-9. PubMed ID: 17694491
[TBL] [Abstract][Full Text] [Related]
16. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia.
Howanitz E; Pardo M; Smelson DA; Engelhart C; Eisenstein N; Stern RG; Losonczy MF
J Clin Psychiatry; 1999 Jan; 60(1):41-4. PubMed ID: 10074877
[TBL] [Abstract][Full Text] [Related]
18. Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use.
Remington G; Lee J; Agid O; Takeuchi H; Foussias G; Hahn M; Fervaha G; Burton L; Powell V
Expert Opin Drug Saf; 2016 Sep; 15(9):1193-203. PubMed ID: 27207070
[TBL] [Abstract][Full Text] [Related]
19. Clozapine treatment after agranulocytosis induced by classic neuroleptics.
Bauer M; Mackert A
J Clin Psychopharmacol; 1994 Feb; 14(1):71-3. PubMed ID: 7908676
[TBL] [Abstract][Full Text] [Related]
20. Prescribing trends and safety of clozapine in an older persons mental health population.
Law A; Croucher M
Int Psychogeriatr; 2019 Dec; 31(12):1823-1829. PubMed ID: 30894236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
